vs

Side-by-side financial comparison of Editas Medicine, Inc. (EDIT) and UNIVERSAL HEALTH REALTY INCOME TRUST (UHT). Click either name above to swap in a different company.

Editas Medicine, Inc. is the larger business by last-quarter revenue ($24.7M vs $24.5M, roughly 1.0× UNIVERSAL HEALTH REALTY INCOME TRUST). UNIVERSAL HEALTH REALTY INCOME TRUST runs the higher net margin — 17.7% vs -22.7%, a 40.4% gap on every dollar of revenue. On growth, UNIVERSAL HEALTH REALTY INCOME TRUST posted the faster year-over-year revenue change (-0.7% vs -19.2%). Over the past eight quarters, Editas Medicine, Inc.'s revenue compounded faster (366.9% CAGR vs -1.3%).

Editas Medicine, Inc.,, is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.

Universal Health Services, Inc. (UHS) is an American Fortune 500 company that provides hospital and healthcare services, based in King of Prussia, Pennsylvania. In 2024, UHS reported total revenues of $15.8 billion.

EDIT vs UHT — Head-to-Head

Bigger by revenue
EDIT
EDIT
1.0× larger
EDIT
$24.7M
$24.5M
UHT
Growing faster (revenue YoY)
UHT
UHT
+18.5% gap
UHT
-0.7%
-19.2%
EDIT
Higher net margin
UHT
UHT
40.4% more per $
UHT
17.7%
-22.7%
EDIT
Faster 2-yr revenue CAGR
EDIT
EDIT
Annualised
EDIT
366.9%
-1.3%
UHT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
EDIT
EDIT
UHT
UHT
Revenue
$24.7M
$24.5M
Net Profit
$-5.6M
$4.3M
Gross Margin
Operating Margin
-31.3%
34.7%
Net Margin
-22.7%
17.7%
Revenue YoY
-19.2%
-0.7%
Net Profit YoY
87.6%
-7.2%
EPS (diluted)
$0.03
$0.32

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EDIT
EDIT
UHT
UHT
Q4 25
$24.7M
$24.5M
Q3 25
$7.5M
$25.3M
Q2 25
$3.6M
$24.9M
Q1 25
$4.7M
$24.5M
Q4 24
$30.6M
$24.6M
Q3 24
$61.0K
$24.5M
Q2 24
$513.0K
$24.7M
Q1 24
$1.1M
$25.1M
Net Profit
EDIT
EDIT
UHT
UHT
Q4 25
$-5.6M
$4.3M
Q3 25
$-25.1M
$4.0M
Q2 25
$-53.2M
$4.5M
Q1 25
$-76.1M
$4.8M
Q4 24
$-45.4M
$4.7M
Q3 24
$-62.1M
$4.0M
Q2 24
$-67.6M
$5.3M
Q1 24
$-62.0M
$5.3M
Operating Margin
EDIT
EDIT
UHT
UHT
Q4 25
-31.3%
34.7%
Q3 25
-325.4%
33.2%
Q2 25
-1440.6%
35.6%
Q1 25
-1635.1%
36.8%
Q4 24
-152.2%
37.6%
Q3 24
-107649.2%
34.7%
Q2 24
-14016.2%
38.7%
Q1 24
-5902.3%
37.6%
Net Margin
EDIT
EDIT
UHT
UHT
Q4 25
-22.7%
17.7%
Q3 25
-333.0%
15.9%
Q2 25
-1487.8%
18.1%
Q1 25
-1633.5%
19.5%
Q4 24
-148.3%
18.9%
Q3 24
-101870.5%
16.3%
Q2 24
-13178.8%
21.3%
Q1 24
-5458.1%
21.1%
EPS (diluted)
EDIT
EDIT
UHT
UHT
Q4 25
$0.03
$0.32
Q3 25
$-0.28
$0.29
Q2 25
$-0.63
$0.32
Q1 25
$-0.92
$0.34
Q4 24
$-0.55
$0.34
Q3 24
$-0.75
$0.29
Q2 24
$-0.82
$0.38
Q1 24
$-0.76
$0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EDIT
EDIT
UHT
UHT
Cash + ST InvestmentsLiquidity on hand
$146.6M
$6.7M
Total DebtLower is stronger
$374.8M
Stockholders' EquityBook value
$27.3M
$152.4M
Total Assets
$186.5M
$564.9M
Debt / EquityLower = less leverage
2.46×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EDIT
EDIT
UHT
UHT
Q4 25
$146.6M
$6.7M
Q3 25
$165.6M
$6.9M
Q2 25
$178.5M
$6.6M
Q1 25
$221.0M
$7.0M
Q4 24
$269.9M
$7.1M
Q3 24
$265.1M
$6.4M
Q2 24
$279.1M
$5.6M
Q1 24
$296.2M
$7.7M
Total Debt
EDIT
EDIT
UHT
UHT
Q4 25
$374.8M
Q3 25
Q2 25
Q1 25
Q4 24
$57.4M
$368.4M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
EDIT
EDIT
UHT
UHT
Q4 25
$27.3M
$152.4M
Q3 25
$13.5M
$158.6M
Q2 25
$19.2M
$165.2M
Q1 25
$62.4M
$172.2M
Q4 24
$134.3M
$179.5M
Q3 24
$175.6M
$181.6M
Q2 24
$232.0M
$190.7M
Q1 24
$294.4M
$196.5M
Total Assets
EDIT
EDIT
UHT
UHT
Q4 25
$186.5M
$564.9M
Q3 25
$201.8M
$568.0M
Q2 25
$210.6M
$573.0M
Q1 25
$263.7M
$573.5M
Q4 24
$341.6M
$580.9M
Q3 24
$327.6M
$584.3M
Q2 24
$384.8M
$586.6M
Q1 24
$440.3M
$596.2M
Debt / Equity
EDIT
EDIT
UHT
UHT
Q4 25
2.46×
Q3 25
Q2 25
Q1 25
Q4 24
0.43×
2.05×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EDIT
EDIT
UHT
UHT
Operating Cash FlowLast quarter
$-36.4M
$49.1M
Free Cash FlowOCF − Capex
$-36.4M
FCF MarginFCF / Revenue
-147.3%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
11.35×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EDIT
EDIT
UHT
UHT
Q4 25
$-36.4M
$49.1M
Q3 25
$-30.8M
$10.2M
Q2 25
$-50.2M
$13.7M
Q1 25
$-47.8M
$11.6M
Q4 24
$-50.8M
$46.9M
Q3 24
$-52.6M
$9.9M
Q2 24
$-57.1M
$12.1M
Q1 24
$-49.9M
$11.7M
Free Cash Flow
EDIT
EDIT
UHT
UHT
Q4 25
$-36.4M
Q3 25
$-31.3M
Q2 25
Q1 25
$-47.9M
Q4 24
$-51.3M
Q3 24
$-55.5M
Q2 24
$-60.6M
Q1 24
$-51.7M
FCF Margin
EDIT
EDIT
UHT
UHT
Q4 25
-147.3%
Q3 25
-414.6%
Q2 25
Q1 25
-1028.6%
Q4 24
-167.6%
Q3 24
-90998.4%
Q2 24
-11804.3%
Q1 24
-4558.9%
Capex Intensity
EDIT
EDIT
UHT
UHT
Q4 25
0.2%
Q3 25
5.7%
Q2 25
0.0%
Q1 25
2.4%
Q4 24
1.8%
Q3 24
4788.5%
Q2 24
681.1%
Q1 24
164.8%
Cash Conversion
EDIT
EDIT
UHT
UHT
Q4 25
11.35×
Q3 25
2.54×
Q2 25
3.05×
Q1 25
2.43×
Q4 24
10.06×
Q3 24
2.48×
Q2 24
2.30×
Q1 24
2.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EDIT
EDIT

Segment breakdown not available.

UHT
UHT

Reportable Segment Aggregation Before Other Operating Segment$23.1M94%
Equity Method Investment Nonconsolidated Investee Or Group Of Investees$2.3M9%

Related Comparisons